Literature DB >> 31501607

The benefits and risks of mass antibiotic use for reducing child mortality.

Zulfiqar A Bhutta1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31501607     DOI: 10.1038/s41591-019-0576-2

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial.

Authors:  Thuy Doan; Armin Hinterwirth; Ahmed M Arzika; Sun Y Cotter; Kathryn J Ray; Kieran S O'Brien; Lina Zhong; Eric D Chow; Zhaoxia Zhou; Susie L Cummings; Dionna Fry; Catherine E Oldenburg; Lee Worden; Travis C Porco; Jeremy D Keenan; Thomas M Lietman
Journal:  Open Forum Infect Dis       Date:  2018-07-24       Impact factor: 3.835

  1 in total
  2 in total

1.  Indirect effect of oral azithromycin on the gut resistome of untreated children: a randomized controlled trial.

Authors:  Catherine E Oldenburg; Armin Hinterwirth; Lee Worden; Ali Sié; Clarisse Dah; Lucienne Ouermi; Boubacar Coulibaly; Lina Zhong; Cindi Chen; Kevin Ruder; Thomas M Lietman; Jeremy D Keenan; Thuy Doan
Journal:  Int Health       Date:  2021-02-24       Impact factor: 2.473

2.  The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Houndé, Burkina Faso, and Bougouni, Mali.

Authors:  Mphatso Dennis Phiri; Matthew Cairns; Issaka Zongo; Frederic Nikiema; Modibo Diarra; Rakiswendé Serge Yerbanga; Amadou Barry; Amadou Tapily; Samba Coumare; Ismaila Thera; Irene Kuepfer; Paul Milligan; Halidou Tinto; Alassane Dicko; Jean Bosco Ouédraogo; Brian Greenwood; Daniel Chandramohan; Issaka Sagara
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.